Honghao Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Honghao Wang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Fanghui Zhao
Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
101 shared publications - Meiwen Yuan
Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
97 shared publications - Shangying Hu
Chinese Academy of Medical Sciences and Peking Union Medical College
97 shared publications - Xuelian Zhao
Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
97 shared publications Kunpeng Xu
4 shared publications- Liuye Huang
Public Health Sciences Division Fred Hutchinson Cancer Center Seattle Washington USA
4 shared publications
Latest Publications
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Temporal Trends and Projection of Cancer Attributable to Human Papillomavirus Infection in China, 2007–2030
Supplementary Data from Temporal Trends and Projection of Cancer Attributable to Human Papillomavirus Infection in China, 2007–2030
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Temporal Trends and Projection of Cancer Attributable to Human Papillomavirus Infection in China, 2007–2030
Supplementary Data from Temporal Trends and Projection of Cancer Attributable to Human Papillomavirus Infection in China, 2007–2030
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006–2030: A Bayesian Age-Period-Cohort Modeling Study
Figure S4 age-period-cohort effect on cervical cancer mortality rates in China between 2006 to 2016.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006–2030: A Bayesian Age-Period-Cohort Modeling Study
Figure S4 age-period-cohort effect on cervical cancer mortality rates in China between 2006 to 2016.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Table S4 from Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006–2030: A Bayesian Age-Period-Cohort Modeling Study
Table S4 shows average age and standardized average age at death for cervical cancer between 2006 to 2030.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006–2030: A Bayesian Age-Period-Cohort Modeling Study
Table S4 shows average age and standardized average age at death for cervical cancer between 2006 to 2030.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Table S6 from Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006–2030: A Bayesian Age-Period-Cohort Modeling Study
Table S6 shows trends for age-specific cervical cancer incidence and mortality rates by region in China between 2017 to 2030.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006–2030: A Bayesian Age-Period-Cohort Modeling Study
Table S6 shows trends for age-specific cervical cancer incidence and mortality rates by region in China between 2017 to 2030.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Data from Temporal Trends and Projection of Cancer Attributable to Human Papillomavirus Infection in China, 2007–2030
Background:Information on temporal trends of cancer attributable to human papillomavirus (HPV) in China is limited.Methods:Cancer incidence and mortality during 2007 to 2015 were extracted from the Chinese Cancer Registry Annual Report and the national population from the National Bureau of Statistics. HPV-attributable cancer burden and the average annual percentage change during 2007 to 2015 were estimated and cancer burden during 2016 to 2030 was projected.Results:HPV-attributable cancer cases have increased by 3.8% [95% confidence interval (CI), 2.9%–4.8%] annually from 85,125 to 113,558 and age-standardized incidence rate (ASIR) rose by 3.0% (95% CI, 2.5%–3.5%) from 4.67 to 5.83 per 100,000 persons during 2007 to 2015. Cervical, female anal, and vulva cancer cases have increased by 3.8% (95% CI, 2.8%–4.7%), 6.5% (95% CI, 1.2%–12.2%), and 3.7% (95% CI, 1.6%–5.8%) per year. Male anal and oropharyngeal cancer cases have elevated by 7.5% (95% CI, 2.8%–12.5%) and 4.4% (95% CI, 2.4%–6.3%) annually. The increases of cervical and anal cancer were most rapid among those aged 50 and older. HPV-attributable cancer deaths and mortality rate have risen by 4.7% (95% CI, 2.9%–6.7%) and 3.3% (95% CI, 0.9%–5.8%) respectively. HPV-attributable cancer cases and ASIR are projected to reach 214,077 and 9.35 of 100,000 persons by 2030 respectively, with 87.7% being cervical cancer, and anal cancer cases are expected to triple.Conclusions:HPV-attributable cancer burden has largely increased in the past and will keep rising for the next decade. Cervical cancer control should be the priority and anal cancer prevention should be addressed.Impact:This study supplies fundamental evidence for policy-making on HPV-attributable cancer control.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Temporal Trends and Projection of Cancer Attributable to Human Papillomavirus Infection in China, 2007–2030
Background:Information on temporal trends of cancer attributable to human papillomavirus (HPV) in China is limited.Methods:Cancer incidence and mortality during 2007 to 2015 were extracted from the Chinese Cancer Registry Annual Report and the national population from the National Bureau of Statistics. HPV-attributable cancer burden and the average annual percentage change during 2007 to 2015 were estimated and cancer burden during 2016 to 2030 was projected.Results:HPV-attributable cancer cases have increased by 3.8% [95% confidence interval (CI), 2.9%–4.8%] annually from 85,125 to 113,558 and age-standardized incidence rate (ASIR) rose by 3.0% (95% CI, 2.5%–3.5%) from 4.67 to 5.83 per 100,000 persons during 2007 to 2015. Cervical, female anal, and vulva cancer cases have increased by 3.8% (95% CI, 2.8%–4.7%), 6.5% (95% CI, 1.2%–12.2%), and 3.7% (95% CI, 1.6%–5.8%) per year. Male anal and oropharyngeal cancer cases have elevated by 7.5% (95% CI, 2.8%–12.5%) and 4.4% (95% CI, 2.4%–6.3%) annually. The increases of cervical and anal cancer were most rapid among those aged 50 and older. HPV-attributable cancer deaths and mortality rate have risen by 4.7% (95% CI, 2.9%–6.7%) and 3.3% (95% CI, 0.9%–5.8%) respectively. HPV-attributable cancer cases and ASIR are projected to reach 214,077 and 9.35 of 100,000 persons by 2030 respectively, with 87.7% being cervical cancer, and anal cancer cases are expected to triple.Conclusions:HPV-attributable cancer burden has largely increased in the past and will keep rising for the next decade. Cervical cancer control should be the priority and anal cancer prevention should be addressed.Impact:This study supplies fundamental evidence for policy-making on HPV-attributable cancer control.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006–2030: A Bayesian Age-Period-Cohort Modeling Study
Figure S1 shows trends for incidence cases during 2006−2016 and predicted from 2017 to 2030 in China.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006–2030: A Bayesian Age-Period-Cohort Modeling Study
Figure S1 shows trends for incidence cases during 2006−2016 and predicted from 2017 to 2030 in China.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006–2030: A Bayesian Age-Period-Cohort Modeling Study
Figure S2 shows trends for deaths during 2006−2016 and predicted from 2017 to 2030 in China.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006–2030: A Bayesian Age-Period-Cohort Modeling Study
Figure S2 shows trends for deaths during 2006−2016 and predicted from 2017 to 2030 in China.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Table S1 from Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006–2030: A Bayesian Age-Period-Cohort Modeling Study
Table S1 shows average age and standardized average age at diagnosis for cervical cancer between 2006 to 2030.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006–2030: A Bayesian Age-Period-Cohort Modeling Study
Table S1 shows average age and standardized average age at diagnosis for cervical cancer between 2006 to 2030.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Table S3 from Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006–2030: A Bayesian Age-Period-Cohort Modeling Study
Table S3 shows proportion of incidence cases by age group between 2006 to 2016.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006–2030: A Bayesian Age-Period-Cohort Modeling Study
Table S3 shows proportion of incidence cases by age group between 2006 to 2016.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006–2030: A Bayesian Age-Period-Cohort Modeling Study
Figure S3 shows age-period-cohort effect on cervical cancer incidence rates in China between 2006 to 2016.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006–2030: A Bayesian Age-Period-Cohort Modeling Study
Figure S3 shows age-period-cohort effect on cervical cancer incidence rates in China between 2006 to 2016.